Treatment of Chronic Migraine Headaches. (NCT03220113) | Clinical Trial Compass
UnknownPhase 1/2
Treatment of Chronic Migraine Headaches.
United States100 participantsStarted 2017-07-01
Plain-language summary
The purpose of the study is assessment of the safety and efficacy of the De-Novo therapy in the treatment of craniofacial neuralgia and migraine headaches.This is an open-label study of simultaneous administration of combination of dexamethasone, lidocaine, and thiamine into the trigeminal nerve branches as well as greater and lesser occipital nerve bilaterally in one session.
Patients who meet the exclusion and inclusion criteria are eligible for trial if they have experienced chronic migraine and craniofacial pain not responding to other prior therapies.
Who can participate
Age range10 Years – 90 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* • Age: 10-90 years
* Ability to describe headache and its symptoms
* Ability to read, comprehend, and legibly and reliably record information
* Ability to provide written, informed consent, and respond to pre and post treatment questionnaires, children's guardian accepts responsibility. Willingness and ability to comply with the study scheduled visits, treatment plans, laboratory tests and other procedures
* Already diagnosed with chronic craniofacial neuralgia and chronic migraine headache
* Exhausted all or most of available abortive and preventive treatment modalities.
Exclusion Criteria:
* • Uncontrollable hypertension, acute Myocardial Infarct within last 6 months
* History of cerebral vascular aneurysm/known atherosclerosis of cerebral system, brain tumor
* Implanted of neuro-stimulator, trigeminal tractotomy, neurectomy partial or complete, history of gamma knife treatment, microsurgical decompression procedure.
* Hypersensitivity or allergy to any components of De-Novo formula
* Presence or known anatomic craniofacial deformities or severe spondylosis/spondylolisthesis of cervical spine, profound dental caries, Maxillofacial deformities
* Pregnancy and current breast feeding status
* Headaches attribute to acute head and neck injuries, chronicity of cervicogenic headaches
* Skin infection or micro abscesses dermatogen or dental, ongoing treatment for Methicillin Resistant Streptococcus Aureus ( MRSA) unless treatment …
What they're measuring
1
Assessment of the safety to the De-Novo treatment formula in study patients